20356 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS
#602Maintenance of platelet inhibition during antiplatelet therapy
#603Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#604Therapeutic pyrazolyl thienopyridines
#605Methods for Treating Acute Myocardial Infarctions and Associated Disorders
#606METHODS FOR TREATING OR SCREENING FOR COMPOUNDS FOR THE TREATMENT OF SEPSIS
#607Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#608CC-1065 analogs and their conjugates
#609METHOD FOR PRODUCING SOLID PREPARATION
#610NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND
#611COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#612VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR
#613Preferred Combination Therapy
#6144,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene compounds
#615THE HYDROSULFATE OF PRASUGREL, ITS PHARMACEUTICAL COMBINATION AND USE THEREOF
#616Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base
#617Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds
#618Diamine Derivatives
#619Benzoxepin PI3K inhibitor compounds and methods of use
#620Methods for the assessment of drug response
#621METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
#622COMPOSITE PREPARATION
#623Pyridothiophene Compounds
#624Combination of Oral Medicaments Bonded by a Wrapping
#625Treatment method for anemia
#626METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
#627Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#628Compounds and methods for the treatment of vascular disease
#629Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
#630Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
#631Cancer therapy
#632PHARMACEUTICAL COMPOSITION HAVING IMPROVED STORAGE STABILITY
#633Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction
#634Analogues of cilostazol
#635ANTI-MITOTIC AGENT AND AURORA KINASE INHIBITOR COMBINATION AS ANTI-CANCER TREATMENT
#636Pyrrolidine compounds
#637Treating alzheimer's disease and osteoporosis and reducing aging
#638METHODS FOR TREATING ACUTE MYOCARDIAL INFARCTIONS AND ASSOCIATED DISORDERS
#639ARTICLE OF MANUFACTURE FOR PRASUGREL
#640Modulators of cystic fibrosis transmembrane conductance regulator
#641MODIFIED RELEASE CLOPIDOGREL FORMULATION
#642Modulation of factor 11 expression
#643COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES
#644Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#645COMPOSITION FOR PREVENTING OR TREATING THROMBUS- OR EMBOLUS- ASSOCIATED DISEASE
#646METHODS FOR TREATING HEPATITIS C
#647W/O/W EMULSION COMPOSITION
#648Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
#649DIAMINE DERIVATIVES
#650NOVEL STABLE PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULFATE AND PROCESS OF PREPARATION THEREOF
#651Methods for treating inflammatory disorders
#652Fused multicyclic compounds as protein kinase inhibitors
#653AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
#654Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
#655Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#656Stable pharmaceutical composition
#657CONCURRENT DRUGS
#658Methods and compositions for treating platelet-related disorders
#659SOLID MEDICINAL PREPARATION CONTAINING MANNITOL OR LACTOSE
#660Thieno [2,3-b] pyridine compounds with mGluR activity
#661Fungal cell wall synthesis gene
#6624,7-DIHYDROTHIENO[2,3-B]PYRIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#663FILM-COATED PREPARATION HAVING IMPROVED STABILITY
#664PRASUGREL PHARMACEUTICAL FORMULATIONS
#665METHOD FOR THE TREATMENT OF ANTHRAX TOXICITY
#666HETEROCYCLIC INHIBITORS OF PDE4
#667DIAMINE DERIVATIVES
#668Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#669CLOPIDOGREL PHARMACEUTICAL FORMULATIONS
#670Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#671Compounds that enhance Atoh1 expression
#672PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL
#673Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
#674NOVEL COMPOUNDS AND USE OF TETRAHYDROPYRIDOPYRIDOTHIOPHENES
#675Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#676Methods and compounds for treatment of clostridium based infection
#677Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
#678DOSAGE REGIMEN FOR PRASUGREL
#679Assessment of cardiac health and thrombotic risk in a patient
#680Fungal cell wall synthesis gene
#681FUNGAL CELL WALL SYNTHESIS GENE
#682Therapeutic agent for irritable bowel syndrome
#683Treatment of Duchenne muscular dystrophy
#684Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
#685THROMBIN RECEPTOR ANTAGONISTS AS PROPHYLAXIS TO COMPLICATIONS FROM CARDIOPULMONARY SURGERY
#686Formulations of Clopidogrel Bisulphate
#687HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE
#688Phenylalanine derivatives
#689Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye
#690Pharmaceutical formulations comprising an immune response modifier
#691Fungal cell wall synthesis gene
#692METHOD OF PROVIDING HEMOSTASIS IN ANTI-COAGULATED BLOOD
#693COMBINATION ANTICOAGULANT THERAPY WITH A COMPOUND THAT ACTS AS A FACTOR XA INHIBITOR
#694Novel Resinate Complex of S-Clopidogrel and Production Method Thereof
#695Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases
#696COMPOSITIONS AND COMBINATIONS 2
#697Formulation of a Thienopyridine Platelet Aggregation Inhibitor
#698Fungal cell wall synthesis gene
#699Thyroid hormone analogs and methods of use
#700Methods and compositions for treating platelet-related disorders
#701Method of treatment with coadministration of aspirin and prasugrel
#702Treatment Of Cognitive Impairment Using A Selective Dopamine D1 Receptor Agonist
#703Therapeutic pyrazolyl thienopyridines
#704Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#705Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives
#706DIAMINE DERIVATIVES
#707Compounds and use of tetrahydropyridothiophenes
#708Thienopyridine Derivatives
#709Pyridothiophene Compounds
#710THROMBIN RECEPTOR ANTAGONISTS AS PROPHYLAXIS TO COMPLICATIONS FROM CARDIOPULMONARY SURGERY
#711Methods for performing percutaneous coronary intervention
#712Aza-quinolinol phosphonate integrase inhibitor compounds
#713Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#714Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#715Antifungal agent containing heterocyclic compound
#716Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
#717Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#718Pharmaceutical formulation for salts of monobasic acids with clopidogrel
#719Medicinal compositions containing aspirin
#720Nanoparticulate clopidogrel formulations
#721Nanoparticulate clopidogrel and aspirin combination formulations
#722Treatment method for anemia
#723Compositions and methods for treating CNS disorders
#724Fungal cell wall synthesis gene
#725Fungal cell wall synthesis gene
#726Method for treating cardiovascular diseases
#727Method for reducing obstructive hydrocephalus
#728Assessment of cardiac health and thrombotic risk in a patient
#729Pharmaceutically active compounds and methods of use
#730USE OF MELOXICAM IN COMBINATION WITH AN ANTIPLATELET AGENT FOR TREATMENT OF ACUTE CORONARY SYNDROME AND RELATED CONDITIONS
#731Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
#732Methods for treating hepatitis C
#733Combination therapies employing platelet aggregation drugs
#734Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#735Modulation of 5-HT2 receptors as a treatment for cardiovascular diseases
#736Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#737Diamine derivatives
#738Methods and compositions for treating platelet-related disorders
#739Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
#740Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#741Aza-quinolinol phosphonate integrase inhibitor compounds
#742Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#743Diamine derivatives
#744Diamine derivatives
#745Compositions and methods for prevention and treatment of coronavirus and related disorders
#746Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease
#747Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
#748Dry powder compositions with magnesium stearate
#749Methods and compositions using AMPK activators for pharmacological prevention of chronic pain